Bottom line
ETHSX vs SCHLX: the short answer
ETHSX (Eaton Vance Worldwide Health Sciences Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 70% by weight.
SCHLX is cheaper at 1.06% vs 1.18% — a difference of $12 a year per $10,000 invested.
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
ETHSX vs SCHLX side by side
| ETHSX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.18% | 1.06% |
| Annual cost per $10k | $118 | $106 |
| 10-yr cost on $10k (prospectus) | $1,911 | $1,294 |
| Max front load | 5.25% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −1.9% | — |
| 5-yr return (annualized) | +5.3% | — |
| 10-yr return (annualized) | +6.4% | — |
| Best quarter | +14.2% | — |
| Worst quarter | −12.1% | — |
| Net assets (fund) | $757.9M | $231.8M |
| Number of holdings | 42 | 65 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Dec 31, 2024 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of ETHSX's top 25 holdings also appear in SCHLX's top 25.
| Holding | ETHSX | SCHLX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 13.85% |
| AbbVie Inc | 6.46% | 4.90% |
| Johnson & Johnson | 6.45% | 6.19% |
| AstraZeneca PLC | 6.24% | 3.80% |
| UnitedHealth Group Inc | 5.49% | 5.73% |
| Roche Holding AG | 5.44% | 1.24% |
| Merck & Co Inc | 5.08% | 4.85% |
| Bristol-Myers Squibb Co | 4.25% | 1.50% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.45% |
| Gilead Sciences Inc | 3.34% | 2.78% |
| Thermo Fisher Scientific Inc | 2.79% | 3.46% |
| Intuitive Surgical Inc | 2.72% | 2.69% |
| Stryker Corp | 2.21% | 2.61% |
| Boston Scientific Corp | 2.18% | 2.10% |
| Medtronic PLC | 1.80% | 1.54% |
Source: SEC Form N-PORT
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between ETHSX and SCHLX?
Which is cheaper, ETHSX or SCHLX?
Should I own both ETHSX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.